✦ LIBER ✦

COMT inhibition and Parkinson's disease

✍ Scribed by E. Dorflinger; G. Magni; F. Hoffmann

Book ID: 118600366
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 385 KB
Volume: 8
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(98)80057-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical pharmacology and therapeutic us

Clinical pharmacology and therapeutic use of COMT inhibition in Parkinson's disease

✍ Ariel Gordin; David J. Brooks 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 420 KB

Simultaneous MAO-B and COMT inhibition i

Simultaneous MAO-B and COMT inhibition in L-dopa-treated patients with parkinson's disease

✍ Dr. Jukka Lyytinen; Seppo Kaakkola; Sirpa Ahtila; Päivi Tuomainen; Heikki Terävä 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 801 KB

## Abstract The effect of selegiline (L‐deprenyl) on plasma catecholamines, clinical response, and drug tolerability was studied in 13 patients with Parkinson's disease (PD) treated with L‐Dopa/benserazide and entacapone, a peripheral catechol‐__O__‐methyltransferase (COMT) inhibitor, in a placebo‐

Detection of response to COMT inhibition

Detection of response to COMT inhibition in FDOPA PET in advanced Parkinson's disease requires prolonged imaging

✍ Hanna M. Ruottinen; Mikko Niinivirta; Jörgen Bergman; Vesa Oikonen; Olof Solin; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 2 views

4-42-02 Synergism between partial periph

4-42-02 Synergism between partial peripheral inhibition of DOPA decarboxylase and COMT by low doses of carbidopa and entacapone in an animal model of Parkinson's disease

✍ Haapalinna, A.; Lindén, I.-B. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 171 KB

COMT inhibition in the treatment of Park

COMT inhibition in the treatment of Parkinson’s disease

✍ H. M. Ruottinen; U. K. Rinne 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 99 KB

Parkinson's Disease || Complex I Inhibit

Parkinson's Disease || Complex I Inhibition, Rotenone and Parkinson's Disease

✍ Betarbet, Ranjita 📂 Article 📅 2008 🏛 Elsevier 🌐 English ⚖ 216 KB

Parkinson’s disease is the second most prevalent neurodegenerative disease and is characterized by the irreversible loss of dopamine neurons. Despite its high prevalence in society and many decades of research, the origin of the pathogenesis and the molecular determinants involved in the disorder ha